Navigation Links
unduly in Medical News

Do not get unduly stressed or emotional as it may affect the heart!

An old adage “prevention is better than cure” is the mantra for a new study that says avoid stress and emotions to keep a healthy heart. // Strategies to manage stress in Americans were discussed at the American forum. According to research 20 percent of Americans are worried that stress...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...chieve favorable clinical outcomes and to have the company's LEVADEX(TM) product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results

...to achieve favorable clinical outcomes and to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says

...nfluences -- Research norms dictate that any payments associated with the trial be examined as part of the ethical review process and payments cannot unduly encourage participation. Standard practice is to reimburse for meals, transportation and similar out-of-pocket expenses. To view th...

MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

...to achieve favorable clinical outcomes or to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints

... release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. Actual results may differ materially from current expectations based on risks ...

Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention

... services for children with autism including an initial exam and evaluation for speech therapy. "This is a reasonable new offering which does not unduly create a price impact on customer groups that would affect their ability to continue to provide health care coverage to their employees," Simmer said....

New Virtual Health Assistant Introduced

... to all of our patients. HealtheTrax(TM) gives us the ability to monitor patients through the critical first 12 weeks of treatment and beyond without unduly burdening either the patients or our staff. We see this as the first step towards a more comprehensive sleep management program." "We believe th...

Advocates for Youth Applauds Court Ruling on EC Age Restriction

...about an over-the-counter drug application. Depositions of senior FDA officials by the Center in 2006 indicated that the Bush Administration sought to unduly influence the agency during the Plan B application review process. Testimony also indicated that officials involved in the decision-making process we...

Federal Court Rules FDA Must Reconsider Plan B Decision

...bout an over-the-counter drug application. Depositions of senior FDA officials by the Center in 2006 indicated that the Bush Administration sought to unduly influence the agency during the Plan B application review process. Testimony also indicated that officials involved in the decision-making process we...
unduly in Medical Technology

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

...al use by the U.S. Food and Drug Administration, including but not limited to approval for use as a first line therapy. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting

... uncertainties relating to the development, clinical testing and potential commercialization of our product candidates. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology

... Risk Factors" in the Company's most recent quarterly report on Form 10-Q for the quarter ended March 31, 2008 filed with the SEC. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. The Company undertakes no duty to publicly announce or report re...

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

...elating to the development and commercialization of product candidates incorporating MAP Pharmaceuticals' technologies. The reader is cautioned not to unduly rely on the forward- looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective

...the ClosureFAST catheter, customer and physician preferences, and the experience of other physicians with our products. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward- looking statements except as requ...

Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis

...-K for the year ended December 31, 2006 and updated in Item 1A. Risk Factors in our Form 10-Q for the quarter ended June 30, 2007. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. We undertake no duty to publicly announce or report revisions to...

Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference

... in our report on Form 10-K for the year ended December 31, 2006 as updated in its Form 10-Q for the quarter ended March 31, 2007. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. We undertake no duty to publicly announce or report revisions to...
unduly in Medical Products

WhisperNG Erbium YAG Extended Ablation Laser

Description:...spread over 3-5 days, and occurs simultaneously with the reepithelialization process. The result is a noticeable improvement in skin texture, without unduly exposing the underlying dermis....
Company:Radiancy
unduly in Biological News

Agricultural research key to food security

...take advantage of cutting-edge agricultural technologies, such as genomics and nanotechnology, that have the potential to increase crop yields without unduly stressing the environment. Building such capacity will depend upon overcoming two obstacles: The North-South gap, which delays the transfer of te...

Early administration of antiretroviral therapy can improve survival

...t difficult. With new families of drugs available and new, less toxic combinations, it is now possible to consider instating treatment earlier without unduly affecting the patient's quality of life. The study published in The Lancet , in the framework of the Antiretroviral Therapy Cohort Collaboration ...

Biotechnology needs 21st century patent system: Expert

... Biotechnology discoveries like the method for creating synthetic life forms are at risk of being unduly hindered or taken hostage by private corporations unless patent systems are brought into the 21st century, an expert from The Australian National Univ...
unduly in Biological Technology

MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine

...l outcomes, and that MAP0004 will not be approved for commercial use by the United States Food and Drug Administration. The reader is cautioned not to unduly rely on the forward- looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs

...omes or to have the company's product candidates approved for commercial use by the U.S. Food and Drug Administration. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

...e ability of VNUS to protect its patent position; and the effectiveness of advertising and other promotional campaigns. The reader is cautioned not to unduly rely on these forward-looking statements. The statements in this press release are made as of the date of this press release, even if subsequently mad...

Codexis, Arch Announce Expanded Collaboration

...lating to commercializing growth; and the challenges of managing growth and establishing effective operations in India. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. We expressly disclaim any intent or obligation to update these forward-looking...

VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance

...position; the effectiveness of advertising and other promotional campaigns; and overall economic and market conditions. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as requi...

Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings

... Risk Factors" in the Company's most recent quarterly report on Form 10-Q for the quarter ended March 31, 2008 filed with the SEC. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. The Company undertakes no duty to publicly announce or report re...

VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales

...position; the effectiveness of advertising and other promotional campaigns; and overall economic and market conditions. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as requi...

Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology

...e risks and uncertainties could cause actual results to differ materially from those described in such statements. The reader is cautioned not to rely unduly on these forward-looking statements, which are not a guarantee of future or current performance. Such risks and uncertainties include long-term progra...

MichBio Responds to Governor's Plan to Repeal Tort Reform Laws

...regulatory duties, but allowing for punishment of companies that willfully withhold information or interfere with the drug approval process. Let's not unduly raise the risks for the many due to failures of the few, where current law and tort reform already provides for meaningful recourse to the injured. Mi...

The New Green Revolution offers hope to poor farmers and poor consumers

...uch as organic farming arent a part of the solution. Simply, it is to assert the biotechnology may hold the key to feeding the worlds billions without unduly harming the environment. With a careful eye on unintended consequences, the New Green Revolution must continue, informed protests or not. ...
Other Tags
(Date:3/2/2015)... Final Cut Pro X plugin ... from Pixel Film Studios. , “The TranStatic Volume 2 plugin ... Christina Austin, CEO of Pixel Film Studios. “TranStatic Volume 2 ... Pro X editors toolbox.” , With TranStatic Volume 2 users ... altering static scrambling effects from Pixel Film Studios. Users have ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 ... services and manage their practices compliantly and ... integrated all-inclusive solution. The interoperability between ... and a medical practice management system is ... long-term financial sustainability. A referral management and ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 As ... web works co-founders, Michael Burns and Carita Weaver, ... addition to working with the Southlake Chamber of ... i5 web works recently launched a website for ... , A primary communications tool for Hill’s campaign, ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Adults who ... insurance rates for term or universal policies can now ... of the best life insurance companies for single adults ... system at http://quotespros.com/life-insurance.html . , The rate plans ... portal are tied to a number of life protection ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
Other Contents